Patient experience in automated peritoneal dialysis with telemedicine monitoring during the <scp>COVID</scp>‐19 pandemic in Mexico: Qualitative study

Cuevas‐Budhart, Miguel Ángel; Pineda, Ingrid Xiomara Celaya; Perez-Moran, Diana; Villeda, Miguel Ángel Trejo; Madrid, Mercedes Gómez del Pulgar García; Rodríguez-Zamora, Ma Cristina; Ramos-Sánchez, Alfonso; Sierra, José Ramón Paniagua

doi:10.1002/nop2.1377

Cited by 10 publications

(7 citation statements)

References 28 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For those with stable renal function during discharge, 12.8% developed AKI after three months, with 87.1% maintaining stability. The findings underscore the importance of intensive care, targeted interventions, and improved follow-up strategies for CKD patients recovering from COVID-19, emphasizing the severity and long-term consequences of the virus in this vulnerable population [45][46][47]. The study also suggests that CKD patients, particularly those in advanced stages, are susceptible to moderate to severe COVID-19 illness that are comparable to existing literature [48][49][50][51][52].…”

Section: Discussionsupporting

confidence: 68%

Clinical, laboratory, and imaging findings of stage 3-5 chronic kidney disease patients suffering from COVID-19 in Bangladesh: a prospective cross-sectional study

Ullah,

Khanam,

Mondal

et al. 2023

Preprint

View full text Add to dashboard Cite

BackgroundChronic kidney disease (CKD) patients were susceptible to morbidity and mortality once they affected by COVID-19. These patients were more likely to develop severe disease, requiring dialysis, admission to intensive care unit. The aim of this study was to evaluate the presentations and outcomes of COVID-19 in stage 3-5 CKD patients not on dialysis.MethodsThis prospective observational study was conducted in the COVID-19 unit, at Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from September 2020 to August 2021. Hospitalized RT-PCR positive COVID-19 patients with pre-existing CKD having eGFR <60 ml/min/1.73 m2but not yet on dialysis were enrolled. Clinical and laboratory parameters were recorded. Outcomes were observed till discharge from the hospital and followed up after 3 months of survived patients.ResultsOut of 109 patients, the mean age was 58.1(SD: ±15.4) years where 61.5% were male. Common co-morbid conditions were hypertension (89.0%), diabetes mellitus (58.7%) and ischemic heart disease (24.8%). Fever, cough, shortness of breath and fatigue were common presenting features. Most of the patients had moderate (41.3%) and severe (41.3%) COVID-19. Sixty-six patients (60.6%) developed AKI on CKD. Twenty patients (30.3%) required dialysis. Death occurred in 16 patients (14.7%) and 12 patient’s (11%) required ICU admission and 6 patients (9.1%) achieved baseline renal function at discharge. We identified risk factors like low haemoglobin, lymphopenia, high CRP, high procalcitonin, high LDH and low SpO2in patients who did not survive. Seventy-six patients were followed up at 3rd month where 17 patients were lost. Ten patients (27.0%) achieved baseline renal function who had persistent AKI at discharge and 34 patients (87.1%) remained stable who had stable renal function at discharge.ConclusionThe stage 3-5 chronic kidney patients with COVID-19 are vulnerable to severe to critical morbidity and mortality with higher incidence of AKI which demands a special attention to this group of patients.

show abstract

Section: Discussionsupporting

confidence: 68%

Clinical, laboratory, and imaging findings of stage 3-5 chronic kidney disease patients suffering from COVID-19 in Bangladesh: a prospective cross-sectional study

Ullah,

Khanam,

Mondal

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…The process of cluster sampling can be divided into the following steps: (1) The researchers identified the total population as peritoneal dialysis patients in Fujian province; (2) We divided Fujian Province into 6 non-overlapping regions and marked them. Each region is a small group; (3) The ratio of the total number of patients in each region to the…”

Section: Participants and Methods Participantsmentioning

confidence: 99%

“…It can reduce the medical expenses and complication rates for patients while improving treatment effects. 3 APD is a dialysis treatment method that uses a peritoneal dialysis machine for automatic peritoneal dialysis fluid exchange. Before resting at night, the peritoneal dialysis catheter is connected to the machine, and the dialysis parameters are set.…”

Section: Introductionmentioning

confidence: 99%

Factors Influencing the Choice of Automated Peritoneal Dialysis Treatment by Patients Receiving Home Peritoneal Dialysis

Cao,

Hong,

Ruan

et al. 2023

PPA

View full text Add to dashboard Cite

Objective This study was conducted to understand the influencing factors for home peritoneal dialysis patients choosing APD and to provide a scientific basis for improving the completion rate of APD treatment and the follow-up of peritoneal dialysis patients. Methods The study was a cross-sectional questionnaire-based study. A total of 588 patients on peritoneal dialysis were randomly selected from 6 regions in Fujian Province in southern China using a stratified cluster sampling method. Results The mean age of the patients were 56.5 ± 14.73 years. In the univariate analysis, knowledge, user experience and family support were the factors that affected patients’ choice of APD (all P < 0.05) and were positively correlated with the treatment utilization rate. In the multivariate analysis, 3 factors (treatment with APD, knowledge of APD, and family support) remained significantly associated not choosing APD. The selection rate for APD was 2.594 times higher among patients who had received APD than among patients who had never received APD. The selection rate for patients with “a lot of knowledge” about APD was 10.75 times that of patients with “no knowledge”. Conclusion Patients’ knowledge of APD, experience in application and family support were the main factors affecting the choice of APD as a treatment mode ( P < 0.05) and were positively correlated with the treatment utilization rate. Further studies are needed to improve the APD treatment completion rates by modulation the above-mentioned factors. Relevance to Clinical Practice This study provides scientific evidence for improving APD treatment completion rates and improving patient quality of life.

show abstract

“…The COVID-19 pandemic spurred telehealth use and its deployment to support home dialysis occurred worldwide. A few examples include the USA [ 20 , 21 ], Brazil [ 22 , 23 ], China [ 24 ], Mexico [ 25 ] and Dominican Republic [ 26 ].…”

Section: Telehealth Applicationsmentioning

confidence: 99%

Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis

Lew,

Ronco

2024

Clinical Kidney Journal

View full text Add to dashboard Cite

Implementing eHealth requires technological advancement, universal broadband and internet access, and devices to conduct telemedicine and remote patient monitoring in end-stage kidney disease patients receiving home dialysis. Although eHealth was beginning to make inroads in this patient population, the COVID-19 pandemic spurred telemedicine usage when many regulations were waived during the Public Health Emergency to limit the spread of infection by endorsing social distancing. At the same time, two-way communication automatic peritoneal dialysis cyclers were introduced to advance remote patient monitoring. Despite the numerous advantages and potential benefits afforded by both procedures, challenges and untapped resources remain to be addressed. Continuing research to assess the use of eHealth and technological innovation can make eHealth a powerful tool in home dialysis. We review the past, present and future of eHealth and remote patient monitoring in supporting home dialysis.

show abstract

Patient experience in automated peritoneal dialysis with telemedicine monitoring during the COVID‐19 pandemic in Mexico: Qualitative study

Cited by 10 publications

References 28 publications

Clinical, laboratory, and imaging findings of stage 3-5 chronic kidney disease patients suffering from COVID-19 in Bangladesh: a prospective cross-sectional study

Clinical, laboratory, and imaging findings of stage 3-5 chronic kidney disease patients suffering from COVID-19 in Bangladesh: a prospective cross-sectional study

Factors Influencing the Choice of Automated Peritoneal Dialysis Treatment by Patients Receiving Home Peritoneal Dialysis

Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis

Contact Info

Product

Resources

About